Return to the home page
Polonez II
Clinical efficacy of vedolizumab used to treat Crohn's disease under the Drug Program.
PROSPECTIVE OBSERVATIONAL STUDY INVOLVING FATIGUE AND OTHER PATIENT-REPORTED SYMPTOMS
Login
Forgot your password?
Reset your password
Login
The BioStat® company watches over the liquid the course of the study and data analysis.
If you have any questions, please contact the study organizer
BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
tel: 666 069 814; email:
[email protected]
PL/EYV/19/0077a
×
Reset password
E-mail address